Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

Jung Ho Kim, So Hyun Shin, Hyeong Ju Kwon, Nam Yun Cho, Gyeong Hoon Kang

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

CpG island methylator phenotype (CIMP) refers to a subset of colorectal cancers (CRCs) that are characterized by concordant hypermethylation of multiple CpG island loci. CIMP+ CRCs have peculiar clinicopathological features. However, controversy exists over prognostic implications of CIMP in CRCs. We analyzed 320 cases of CRCs for their CIMP status using the MethyLight assay and determined clinicopathological features and prognostic implications of CIMP alone or in combination with microsatellite instability (MSI). With methylation of five or more markers among eight markers examined, CIMP+ tumors were significantly associated with female gender, proximal tumor location, poor differentiation, nodal metastasis, more advanced cancer, BRAF mutations, MSI, and poor prognosis (all P values <0.05). Ogino's combined eight-marker panel outperformed the Ogino and the Laird five-marker panels in detecting these features. Of the four molecular subtypes generated by the combination of CIMP and MSI status, the CIMP+/MSI- subtype showed the worst clinical outcome (P∈=∈0.0003). However, poor prognosis of CIMP+/MSI- subtype was found to be attributed to BRAF mutation. In conclusion, the CIMP+/MSI- subtype tends to present with distinct clinicopathological and molecular features and shows the worst clinical outcome among the four molecular subtypes of CRCs.

Original languageEnglish
Pages (from-to)485-494
Number of pages10
JournalVirchows Archiv
Volume455
Issue number6
DOIs
Publication statusPublished - 2009 Nov 13

Fingerprint

CpG Islands
Colorectal Neoplasms
Microsatellite Instability
Phenotype
Neoplasms
Mutation
Methylation
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Kim, Jung Ho ; Shin, So Hyun ; Kwon, Hyeong Ju ; Cho, Nam Yun ; Kang, Gyeong Hoon. / Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. In: Virchows Archiv. 2009 ; Vol. 455, No. 6. pp. 485-494.
@article{d5d41a925056468fb90c60403161f014,
title = "Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers",
abstract = "CpG island methylator phenotype (CIMP) refers to a subset of colorectal cancers (CRCs) that are characterized by concordant hypermethylation of multiple CpG island loci. CIMP+ CRCs have peculiar clinicopathological features. However, controversy exists over prognostic implications of CIMP in CRCs. We analyzed 320 cases of CRCs for their CIMP status using the MethyLight assay and determined clinicopathological features and prognostic implications of CIMP alone or in combination with microsatellite instability (MSI). With methylation of five or more markers among eight markers examined, CIMP+ tumors were significantly associated with female gender, proximal tumor location, poor differentiation, nodal metastasis, more advanced cancer, BRAF mutations, MSI, and poor prognosis (all P values <0.05). Ogino's combined eight-marker panel outperformed the Ogino and the Laird five-marker panels in detecting these features. Of the four molecular subtypes generated by the combination of CIMP and MSI status, the CIMP+/MSI- subtype showed the worst clinical outcome (P∈=∈0.0003). However, poor prognosis of CIMP+/MSI- subtype was found to be attributed to BRAF mutation. In conclusion, the CIMP+/MSI- subtype tends to present with distinct clinicopathological and molecular features and shows the worst clinical outcome among the four molecular subtypes of CRCs.",
author = "Kim, {Jung Ho} and Shin, {So Hyun} and Kwon, {Hyeong Ju} and Cho, {Nam Yun} and Kang, {Gyeong Hoon}",
year = "2009",
month = "11",
day = "13",
doi = "10.1007/s00428-009-0857-0",
language = "English",
volume = "455",
pages = "485--494",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "6",

}

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. / Kim, Jung Ho; Shin, So Hyun; Kwon, Hyeong Ju; Cho, Nam Yun; Kang, Gyeong Hoon.

In: Virchows Archiv, Vol. 455, No. 6, 13.11.2009, p. 485-494.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

AU - Kim, Jung Ho

AU - Shin, So Hyun

AU - Kwon, Hyeong Ju

AU - Cho, Nam Yun

AU - Kang, Gyeong Hoon

PY - 2009/11/13

Y1 - 2009/11/13

N2 - CpG island methylator phenotype (CIMP) refers to a subset of colorectal cancers (CRCs) that are characterized by concordant hypermethylation of multiple CpG island loci. CIMP+ CRCs have peculiar clinicopathological features. However, controversy exists over prognostic implications of CIMP in CRCs. We analyzed 320 cases of CRCs for their CIMP status using the MethyLight assay and determined clinicopathological features and prognostic implications of CIMP alone or in combination with microsatellite instability (MSI). With methylation of five or more markers among eight markers examined, CIMP+ tumors were significantly associated with female gender, proximal tumor location, poor differentiation, nodal metastasis, more advanced cancer, BRAF mutations, MSI, and poor prognosis (all P values <0.05). Ogino's combined eight-marker panel outperformed the Ogino and the Laird five-marker panels in detecting these features. Of the four molecular subtypes generated by the combination of CIMP and MSI status, the CIMP+/MSI- subtype showed the worst clinical outcome (P∈=∈0.0003). However, poor prognosis of CIMP+/MSI- subtype was found to be attributed to BRAF mutation. In conclusion, the CIMP+/MSI- subtype tends to present with distinct clinicopathological and molecular features and shows the worst clinical outcome among the four molecular subtypes of CRCs.

AB - CpG island methylator phenotype (CIMP) refers to a subset of colorectal cancers (CRCs) that are characterized by concordant hypermethylation of multiple CpG island loci. CIMP+ CRCs have peculiar clinicopathological features. However, controversy exists over prognostic implications of CIMP in CRCs. We analyzed 320 cases of CRCs for their CIMP status using the MethyLight assay and determined clinicopathological features and prognostic implications of CIMP alone or in combination with microsatellite instability (MSI). With methylation of five or more markers among eight markers examined, CIMP+ tumors were significantly associated with female gender, proximal tumor location, poor differentiation, nodal metastasis, more advanced cancer, BRAF mutations, MSI, and poor prognosis (all P values <0.05). Ogino's combined eight-marker panel outperformed the Ogino and the Laird five-marker panels in detecting these features. Of the four molecular subtypes generated by the combination of CIMP and MSI status, the CIMP+/MSI- subtype showed the worst clinical outcome (P∈=∈0.0003). However, poor prognosis of CIMP+/MSI- subtype was found to be attributed to BRAF mutation. In conclusion, the CIMP+/MSI- subtype tends to present with distinct clinicopathological and molecular features and shows the worst clinical outcome among the four molecular subtypes of CRCs.

UR - http://www.scopus.com/inward/record.url?scp=73449118889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449118889&partnerID=8YFLogxK

U2 - 10.1007/s00428-009-0857-0

DO - 10.1007/s00428-009-0857-0

M3 - Article

C2 - 19911194

AN - SCOPUS:73449118889

VL - 455

SP - 485

EP - 494

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 6

ER -